Related Experiment Video

Updated: Dec 1, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.1K

Favipiravir and COVID-19: A Simplified Summary

Morteza Ghasemnejad-Berenji1, Sarvin Pashapour2

  • 1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran.

Drug Research
|November 11, 2020
PubMed

Insights

This review summarizes clinical trials on favipiravir for treating coronavirus disease 2019 (COVID-19). It examines the antiviral drug

Area of Science:

  • Virology
  • Infectious Diseases
  • Pharmacology

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, emerged in late 2019.
  • No specific antiviral therapies are currently approved for COVID-19 treatment.
  • Repurposing existing antiviral drugs is a rapid strategy for novel infections.

Purpose of the Study:

  • To review clinical trials evaluating favipiravir's efficacy and safety in COVID-19 patients.
  • To consolidate current evidence on favipiravir as a potential COVID-19 treatment.

Main Methods:

  • Literature search for clinical trials on favipiravir for COVID-19.
  • Analysis of study designs, patient populations, and reported outcomes.
  • Synthesis of data regarding efficacy (viral clearance, clinical improvement) and safety (adverse events).

Main Results:

  • Favipiravir, a nucleotide analog, inhibits viral RNA-dependent RNA polymerase.
  • Clinical trials have investigated its potential to reduce viral load and improve symptoms.
  • Safety profiles and specific efficacy data from various trials are being compiled.

Conclusions:

  • Favipiravir shows promise as a potential antiviral treatment for COVID-19.
  • Further comprehensive analysis of clinical trial data is needed to confirm efficacy and safety.
  • Evidence synthesis is crucial for guiding clinical practice and future research.

More Related Videos

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization05:23

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Published on: December 23, 2020

6.4K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.6K

Related Concept Videos

Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
464
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
38.2K